Trial intelligence / Profile preview

Fruquintinib in elderly or ECOG PS 2 advanced non-squamous NSCLC patients unsuitable for chemotherapy

CTR20170532Phase 2Suspended

Sponsor

HUTCHMED

Start

Jul 2018

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1